Clarus Therapeutics Holdings Inc. Gains 19.76%

Wed, Jun 01, 2022 at 05:30 PM
Clarus Therapeutics Holdings Inc. Gains 19.76%

Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) rocketted at $0.5, representing a gain of 19.8%. On Tue, May 31, 2022, CRXT:NASDAQ hit a New 2-Week Intraday High of $0.44. The stock got featured on our News Catalysts scanner on Wed, May 18, 2022 at 10:13 AM in the 'PATENT' category. From Wed, May 18, 2022, the stock recorded 37.50% Up Days and 44.44% Green Days

The stock spiked on Wed, Apr 20, 2022 at $3.94 with a volume of 236M+, and its share price has been moving sideways in recent weeks.

About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.